Score Pharma

Executive Summary

Score Pharma is a US-based, virtual biotech startup founded in 2018, focusing on developing enhanced antibody therapeutics for cancer through its proprietary process technology that improves Antibody-Dependent Cellular Cytotoxicity (ADCC). By leveraging strategic partnerships and a distributed team, the company aims to de-risk and accelerate drug development. Its initial focus is on oncology biosimilars with enhanced efficacy. While still in early stages with no disclosed pipeline or funding, the company's virtual model and technological approach position it to potentially improve existing antibody therapies. However, the lack of clinical data and reliance on partnerships introduces significant uncertainty.

Upcoming Catalysts (preview)

• H1 2027Lead candidate IND filing40% success
• H2 2026Strategic partnership announcement50% success
• 2026Preclinical proof-of-concept data release55% success